PASG

NASDAQStock

Passage Bio, Inc.

$7.35-0.75 (-9.26%)

52-Week Range

$5.27

$19.85

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.77

Volume

45.4K

Avg Volume

41.7K

Performance

-7.22%

-19.40%

+16.55%

YTD

-30.71%

+4.92%

-62.50%

-98.05%

Price Chart

ETF Exposure

PASG is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	1,263	$10K	$2.68B	0.14%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	792	$6K	$40.55B	0.17%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	3	$60	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	138	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$10	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	78,764	$906K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	414	$6K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	35	$556	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	35,200	$405K	$84.10B	0.05%

About PASG ETF Exposure

Passage Bio, Inc. (PASG) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $7.35. Investors can gain exposure to PASG through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PASG, sorted by portfolio weight.